Dr. Douglas J. Robertson joins Medical Advisory Board for PolypDx™
MTI is pleased to announce the addition of Dr. Douglas J. Robertson to our Medical Advisory Board for PolypDx™. Dr. Robertson is Professor of Medicine at the Geisel School of Medicine at Dartmouth, and also Chief of Gastroenterology at the VA Medical Center in White River Junction, Vermont. He is co-chair of the 50,000 patient randomized national trial to look at the effects of screening methods on colorectal cancer mortality. In addition, Dr. Robertson sits on the United States Multi-Society Task Force for Colorectal Cancer, which was responsible for the 2017 update to clinical guidelines for colorectal cancer screening.
Dr. Robertson will join an advisory board of esteemed practitioners and researchers to provide advice and direction, as we work to see our test delivered to patients around the world.
Read more about Dr. Robertson here.